Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Compliance Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half -Year Ended March 31, 2019

 Pursuant to Regulation 40(9) read with Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Compliance Certificate for the half-year ended on March 31, 2019 issued by Roy Jacob & Co., Company Secretaries, the copy of which will be placed before the ensuing meeting of the Board of Directors of the Company. Please take the above on your records.
24-04-2019
Bigul

Genesys International Corporation Ltd - 506109 - Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half-Year Ended On March 31, 2019.

 We are enclosing herewith the Compliance Certificate pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half-year ended on March 31, 2019.
23-04-2019
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Shareholding for the Period Ended March 31, 2019

 Genesys International Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here
20-04-2019
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Statement Of Investor Complaints For The Quarter Ended March 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Vineet ChopraDesignation :- Company Secretary and Compliance Officer
19-04-2019
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Closure of Trading Window

 This is with reference to the circular no. LIST/COMP/01/2019-20 issued by BSE Limited and circular no. NSE/CML/2019/11 issued by National Stock Exchange of India Limited both dated April 02, 2019 pertaining to clarification regarding trading restriction period. In compliance with the aforesaid circulars and pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, we wish to inform you that the trading window for dealing in securities of the Company shall remain closed for all Designated Persons and their immediate Relatives with immediate effect till 48 hours after the declaration of financial results of the Company for the quarter & year ended March 31, 2019. Please take the above on your records.
05-04-2019
Bigul

Genesys International Corporation Ltd - 506109 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 In terms of Securities and Exchange Board of India (Prohibition of Insider Trading) (amendment) Regulations 2018 and SEBI notification dated 31st December, 2018, the Board of Directors, at their meeting held on March 29, 2019, has approved and adopted revised Code of Practice and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. In compliance with the Regulation 8(2) of the Regulation Code of Practice and Procedures for Fair Disclosure of Unpublished Price Sensitive Information is enclosed herewith for your record. You are request to take the above on record.
29-03-2019
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Publication of Un-audited financial results for the third quarter and period ended December 31, 2018 published in the newspaper - The Free Press Journal (English) and Navshakti (Marathi).
18-02-2019
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 The Compensation Committee at its meeting held on February 15, 2019 has approved the allotment of 41,200 equity shares of face value of Rs. 5.00 each pursuant to the exercise of the Stock Options by the eligible employees of the company under the Genesys ESOP Scheme -2010. Consequently, post-allotment the paid-up capital of the company shall stand increased to Rs.15,55,61,560/- divided into 3,11,12,312 Equity Shares of face value of Rs. 5.00 each. These shares shall rank pari passu with the existing equity shares of the Company in all respects. You are requested to take the above on your record.
15-02-2019
Bigul

Genesys International Corporation Ltd - 506109 - Outcome of Board Meeting

 In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today i.e. February 14, 2019 has inter-alia considered and approved the following matters: 1.The Un-audited Standalone Financial Results for the third quarter and nine months ended December 31, 2018. 2.Reconstitution of Stakeholders Relationship Committee as per the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018. In this regard, we are enclosing the following: (i)The Un-audited Standalone Financial Results for the third quarter and nine months ended December 31, 2018. (ii)Limited Review Report of the Statutory Auditors. The meeting of the Board commenced at 5.45 pm and concluded at 7.25 pm. Please take the same on your record.
14-02-2019
Bigul

Raja Lakshmipathy appointed Genesys India MD

 Genesys, a customer experience and contact centre solutions provider, has appointed Raja Lakshmipathy as its India MD.Lakshmipathy will be in charge o
14-02-2019
Next Page
Close

Let's Open Free Demat Account